NOVARTIS | LA-MERE APP. | NOVARTIS/ LA-MERE APP. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 27.3 | 87.2 | 31.3% | View Chart |
P/BV | x | 3.4 | 0.5 | 657.0% | View Chart |
Dividend Yield | % | 4.5 | 0.0 | - |
NOVARTIS LA-MERE APP. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
NOVARTIS Mar-23 |
LA-MERE APP. Mar-23 |
NOVARTIS/ LA-MERE APP. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 763 | 46 | 1,664.7% | |
Low | Rs | 554 | 23 | 2,456.8% | |
Sales per share (Unadj.) | Rs | 153.4 | 7.6 | 2,027.5% | |
Earnings per share (Unadj.) | Rs | 41.9 | 1.4 | 3,033.6% | |
Cash flow per share (Unadj.) | Rs | 44.3 | 1.4 | 3,129.8% | |
Dividends per share (Unadj.) | Rs | 47.50 | 0 | - | |
Avg Dividend yield | % | 7.2 | 0 | - | |
Book value per share (Unadj.) | Rs | 314.2 | 81.6 | 385.2% | |
Shares outstanding (eoy) | m | 24.69 | 5.00 | 493.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 4.3 | 4.5 | 95.0% | |
Avg P/E ratio | x | 15.7 | 24.8 | 63.5% | |
P/CF ratio (eoy) | x | 14.9 | 24.2 | 61.5% | |
Price / Book Value ratio | x | 2.1 | 0.4 | 500.1% | |
Dividend payout | % | 113.5 | 0 | - | |
Avg Mkt Cap | Rs m | 16,262 | 171 | 9,510.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 356 | 2 | 18,466.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 3,787 | 38 | 10,011.6% | |
Other income | Rs m | 581 | 10 | 5,996.9% | |
Total revenues | Rs m | 4,369 | 48 | 9,193.0% | |
Gross profit | Rs m | 651 | -3 | -25,030.8% | |
Depreciation | Rs m | 61 | 0 | 33,666.7% | |
Interest | Rs m | 18 | 0 | - | |
Profit before tax | Rs m | 1,154 | 7 | 16,721.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 120 | 0 | - | |
Profit after tax | Rs m | 1,034 | 7 | 14,979.7% | |
Gross profit margin | % | 17.2 | -6.9 | -249.8% | |
Effective tax rate | % | 10.4 | 0 | - | |
Net profit margin | % | 27.3 | 18.2 | 149.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 7,861 | 17 | 47,267.6% | |
Current liabilities | Rs m | 2,683 | 0 | 925,034.5% | |
Net working cap to sales | % | 136.7 | 43.2 | 316.5% | |
Current ratio | x | 2.9 | 57.3 | 5.1% | |
Inventory Days | Days | 1,201 | 4,220 | 28.5% | |
Debtors Days | Days | 35 | 2 | 2,257.4% | |
Net fixed assets | Rs m | 12,656 | 443 | 2,859.0% | |
Share capital | Rs m | 123 | 50 | 246.8% | |
"Free" reserves | Rs m | 7,634 | 358 | 2,133.1% | |
Net worth | Rs m | 7,757 | 408 | 1,901.9% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,517 | 459 | 4,467.1% | |
Interest coverage | x | 66.9 | 0 | - | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.2 | 0.1 | 224.1% | |
Return on assets | % | 5.1 | 1.5 | 340.8% | |
Return on equity | % | 13.3 | 1.7 | 787.5% | |
Return on capital | % | 15.1 | 1.7 | 892.0% | |
Exports to sales | % | 2.1 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 80 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 80 | 0 | - | |
Fx outflow | Rs m | 946 | 0 | - | |
Net fx | Rs m | -866 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 448 | 5 | 9,781.7% | |
From Investments | Rs m | -1,533 | 20 | -7,651.0% | |
From Financial Activity | Rs m | -305 | -10 | 3,142.3% | |
Net Cashflow | Rs m | -1,389 | 15 | -9,324.2% |
Indian Promoters | % | 0.0 | 66.8 | - | |
Foreign collaborators | % | 70.7 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.7 | 0.0 | - | |
FIIs | % | 0.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 29.3 | 33.2 | 88.3% | |
Shareholders | 41,239 | 8,371 | 492.6% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare NOVARTIS With: ADANI ENTERPRISES REDINGTON MMTC SIRCA PAINTS INDIA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Novartis | LA-MERE APP. | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.87% | -0.71% | 0.45% |
1-Month | 0.85% | -17.43% | 2.55% |
1-Year | 81.60% | 54.44% | 56.14% |
3-Year CAGR | 17.51% | 35.56% | 15.22% |
5-Year CAGR | 8.12% | 40.63% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Novartis share price and the LA-MERE APP. share price.
Moving on to shareholding structures...
The promoters of Novartis hold a 70.7% stake in the company. In case of LA-MERE APP. the stake stands at 66.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Novartis and the shareholding pattern of LA-MERE APP..
Finally, a word on dividends...
In the most recent financial year, Novartis paid a dividend of Rs 47.5 per share. This amounted to a Dividend Payout ratio of 113.5%.
LA-MERE APP. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of Novartis, and the dividend history of LA-MERE APP..
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.